Compare iShares MSCI South Korea ETF (EWY) vs Oscar Health Inc (OSCR) Price & Performance

EWY is trading at $163.67, down 7.52% with significant volatility driven by its heavy concentration in South Korean semiconductor giants Samsung and SK Hynix. The ETF has entered bear market territory, reflecting global tech sector pressures and foreign investor selling. Technical indicators show bearish momentum with RSI near oversold levels at 28, while support sits at $157. Recent news highlights the Kospi Index's 21% decline from YTD highs, creating both risk and potential opportunity.

The outlook remains challenged by semiconductor cycle volatility and concentrated exposure, but long-term AI demand fundamentals provide potential upside. Key risks include single-stock concentration, foreign capital flows, and global tech sentiment shifts. Investors should weigh near-term volatility against structural semiconductor growth drivers.

Oscar Health (OSCR) trades at $29.17, down 6.12% on the day, against a backdrop of volatile earnings and a bullish technical signal. The stock shows strong revenue growth, with 2026 revenue projected at $13.3B, but remains unprofitable with a -0.3% net margin. Recent news highlights its momentum as a value pick, while analyst consensus is mixed with a $22.50 price target below the current price.

The outlook balances rapid top-line expansion and improving cash flow against persistent losses and valuation concerns. The primary opportunity lies in the company's market share gains and tech-driven model within health insurance. Key risks include execution on profitability, competitive pressures, and the stock's premium valuation relative to near-term earnings.